Pharmaceutical composition for treating macular degeneration (WO2012079419)

Author： Wang Shusheng Cunnusamy Khrishen

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.2, 2013-02, pp. : 269-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Vascular Endothelial Growth Factor: A Promising Strategy for Treating Age-Related Macular Degeneration

By Waisbourd Michael Loewenstein Anat Goldstein Michaella Leibovitch Igal

Drugs & Aging, Vol. 24, Iss. 8, 2007-01 ,pp. : 643-662

Adis International

Access to resources Recommend Favorite

The Burden of Age-Related Macular Degeneration

By Schmier Jordana K. Jones Mechelle L. Halpern Michael T.

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 319-334

Adis International

Access to resources Recommend Favorite

Sub-Macular Surgery: Is Still an Option for Age-Related Macular Degeneration?

Current Drug Targets, Vol. 12, Iss. 2, 2011-01 ,pp. : 190-198

Bentham Science Publishers

Access to resources Recommend Favorite

Pegaptanib: In Exudative Age-Related Macular Degeneration

By Siddiqui M. Asif A. Keating Gillian M.

Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. : 1571-1577

Adis International

Access to resources Recommend Favorite

Regular aspirin use linked with macular degeneration

Reactions Weekly, Vol. 1, Iss. 1437, 2013-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite